Biofrontera AG announced that it has established a subsidiary to continue the commercialization of Ameluz® in the United Kingdom. The newly founded Biofrontera UK Ltd. Is based in Cambridge, UK and headed by Ms. Pilar de la Huerta and Dr. Montserrat Foguet as Managing Directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.695 EUR | -6.75% |
|
-9.41% | -68.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-68.00% | 17.86M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- B8FK Stock
- News Biofrontera AG
- Biofrontera AG Announces Executive Appointments to Biofrontera UK Ltd